Urinary Incontinence Devices Market Size, Share, Growth, and Industry Analysis, By Type (External Urinary Incontinence Devices, Internal Urinary Incontinence Devices), By Application (Hospitals, Clinics, Others), Regional Insights and Forecast to 2035

Urinary Incontinence Devices Market Overview

The global Urinary Incontinence Devices Market is forecast to expand from USD 14713.9 million in 2026 to USD 15493.74 million in 2027, and is expected to reach USD 24843.74 million by 2035, growing at a CAGR of 5.3% over the forecast period.

The global Urinary Incontinence Devices Market is expanding steadily, driven by the rising prevalence of urinary incontinence and increasing geriatric populations worldwide. Over 400 million individuals suffer from urinary incontinence globally, with women representing approximately 60% of affected cases. Around 45% of hospitals and clinics now integrate urinary incontinence devices into their treatment protocols. More than 70 countries have introduced awareness campaigns and advanced medical programs to support effective bladder control solutions. The market also benefits from continuous innovations, with over 55% of newly developed devices focusing on non-invasive and wearable technologies to enhance patient comfort and treatment outcomes.

In the United States, the Urinary Incontinence Devices Market accounts for around 35% of the North American market due to its robust healthcare infrastructure and higher patient awareness. More than 25 million Americans are affected by urinary incontinence, with 80% of them being women. Approximately 50% suffer from stress urinary incontinence, while 30% report urge incontinence. Over 6,000 specialized urology centers and nearly 1,200 rehabilitation facilities provide treatment options nationwide. Around 65% of hospitals in the U.S. offer at least one form of incontinence device, supported by strong insurance coverage and the presence of over 15 domestic device manufacturers.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: Approximately 65% rise in the elderly population suffering from urinary incontinence disorders drives device demand.
• Major Market Restraint: Around 40% of patients report surgical complications or discomfort with invasive urinary incontinence devices.
• Emerging Trends: Over 55% growth in adoption of wearable, non-invasive incontinence management systems globally.
• Regional Leadership: Europe contributes about 33% market share, while North America follows with nearly 29% share.
• Competitive Landscape: Top 10 manufacturers hold around 72% of global urinary incontinence device production.
• Market Segmentation: Female patients represent 68% of device use, and disposable devices account for 52% of total utilization.
• Recent Development: Over 45% of new products launched in 2024 feature AI-enabled leakage monitoring and connectivity functions.

Urinary Incontinence Devices Market Latest Trends

The Urinary Incontinence Devices Market has evolved with the rapid development of smart and user-friendly medical technologies. Nearly 45% of women aged 50 and above experience some level of urinary incontinence, fueling product innovation across regions. Hospitals and clinics report a 38% increase in demand for non-surgical pelvic floor therapy and electrical stimulation devices. Around 25% of hospitals globally are deploying sensor-based digital incontinence management systems, improving diagnostic precision and treatment efficiency. 

Urinary Incontinence Devices Market Dynamics

DRIVER

"Rising prevalence of urinary incontinence among aging populations."

The global Urinary Incontinence Devices Market growth is driven by the increasing elderly population, which is expected to reach nearly 1.5 billion individuals by 2050. Currently, 11% of people over the age of 65 suffer from urinary incontinence, while 65% of those affected are women. Hospitals have reported a 42% year-on-year increase in the adoption of urinary incontinence devices, such as slings, pessaries, and artificial urinary sphincters. 

RESTRAINT

"Limited awareness and complications associated with invasive devices."

The Urinary Incontinence Devices Market faces restrictions due to low patient awareness and potential complications of surgical implants. About 38% of patients remain unaware of device-assisted treatment options, relying instead on lifestyle modifications or pharmaceuticals. Nearly 25% of patients undergoing implantation experience mild post-surgical issues or device malfunction, requiring additional procedures. The average cost of implantable urinary incontinence devices is 15% higher than traditional solutions, limiting access for middle-income populations. 

OPPORTUNITY

"Advancements in wearable and sensor-based urinary incontinence management devices."

Technological innovation provides significant growth potential for the Urinary Incontinence Devices Market. Over 35% of the total R&D investment in urology now targets smart, wearable, and sensor-integrated devices. IoT-enabled and AI-assisted urinary incontinence devices have demonstrated over 85% detection accuracy and 50% better treatment adherence. Approximately 120 patents were filed globally in 2024 for urinary incontinence management technologies, marking a 20% increase compared to 2023. The integration of digital health platforms and connected monitoring systems has improved home-based care efficiency by 45%. 

CHALLENGE

"Lack of standardized regulatory frameworks and skilled professionals."

The Urinary Incontinence Devices Market encounters challenges due to inconsistent global regulations and a shortage of trained specialists. Nearly 60% of emerging economies lack well-defined regulatory pathways for device approval, creating entry delays. Even in developed markets, 25% of clinical facilities report an average approval delay of 12–18 months for new devices. The shortage of skilled urologists and trained surgical personnel affects approximately 70% of mid-tier healthcare institutions. 

Urinary Incontinence Devices Market Segmentation 

The Urinary Incontinence Devices Market segmentation is categorized by type and application, each reflecting unique product utilization and end-user patterns. By type, the market is classified into External Urinary Incontinence Devices and Internal Urinary Incontinence Devices. By application, it is divided into Hospitals, Clinics, and Others. External devices account for 54% of the total global demand, while internal devices make up the remaining 46%. Hospitals contribute around 45% of device usage, clinics 33%, and others 22%. This segmentation demonstrates how product diversity and patient preference shape the overall growth trajectory of the global Urinary Incontinence Devices Market.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

External Urinary Incontinence Devices: These non-invasive solutions are the most widely adopted category in the Urinary Incontinence Devices Market, offering wearable and disposable options like external catheters, pads, and clamps. Around 58% of users globally prefer external devices due to comfort, cost-effectiveness, and ease of use. In 2024, adoption in homecare environments increased by 48%, particularly for disposable absorbent pads. Male external catheters account for 35% of total external device sales. Hospitals and clinics represent 45% of the demand, while home users contribute 30%. Integration of smart sensors improved treatment accuracy by nearly 40%, supporting large-scale acceptance across developed and emerging markets.

External Urinary Incontinence Devices Market Size, Share, and CAGR: The global market size is approximately USD 1.85 billion, holding 54% share of the total urinary incontinence devices industry, with a CAGR of 5.6% projected during the assessment period.

Top 5 Major Dominant Countries in the External Urinary Incontinence Devices Segment:

• United States: Market size USD 0.59 billion, 32% share, CAGR 5.8%, driven by advanced homecare systems and large geriatric population.
• Germany: Market size USD 0.26 billion, 14% share, CAGR 5.5%, supported by government reimbursement and healthcare access programs.
• Japan: Market size USD 0.20 billion, 11% share, CAGR 5.6%, owing to aging society and adoption of smart wearable pads.
• United Kingdom: Market size USD 0.17 billion, 9% share, CAGR 5.3%, driven by public hospital procurement of disposable pads.
• China: Market size USD 0.15 billion, 8% share, CAGR 5.7%, led by healthcare modernization and increasing incontinence awareness.

Internal Urinary Incontinence Devices: Internal devices such as slings, artificial urinary sphincters, and pessaries are used in moderate to severe cases requiring surgical treatment. These account for 46% of the global market, driven by high procedural success rates and expanding hospital infrastructure. Around 60% of surgeries for stress urinary incontinence involve internal devices. Female patients account for 65% of total usage. Advancements in implantable materials have reduced complication rates by 18%. Artificial sphincters are widely used in 20% of hospital-based urological surgeries. Demand in Asia-Pacific grew 30% in the last two years, supported by skilled surgical expertise and government hospital expansion.

Internal Urinary Incontinence Devices Market Size, Share, and CAGR: The market size stands at USD 1.57 billion, accounting for 46% of total industry share, growing at a steady CAGR of 5.4% during the study timeline.

Top 5 Major Dominant Countries in the Internal Urinary Incontinence Devices Segment:

• United States: Market size USD 0.47 billion, 30% share, CAGR 5.5%, driven by rising surgical procedures and device innovation.
• France: Market size USD 0.20 billion, 13% share, CAGR 5.3%, with strong adoption of internal implants through national healthcare coverage.
• Japan: Market size USD 0.16 billion, 10% share, CAGR 5.4%, supported by increased adoption of sling surgeries.
• India: Market size USD 0.13 billion, 8% share, CAGR 5.7%, led by healthcare modernization and cost-efficient surgical programs.
• Canada: Market size USD 0.11 billion, 7% share, CAGR 5.3%, driven by aging population and advanced hospital systems.

BY APPLICATION

Hospitals: Hospitals represent the largest application segment, accounting for about 45% of the Urinary Incontinence Devices Market. More than 70% of urinary incontinence-related surgeries are performed in hospital settings. Approximately 65% of hospitals worldwide provide access to urinary management devices. Annual demand for implantable devices has risen by 42%, while usage of external devices in post-surgical recovery has grown by 30%. Government insurance programs in over 40 countries have contributed to high device adoption rates. Hospital-based purchases make up nearly 60% of all institutional procurement, reflecting their dominant role in this market segment globally.

Hospitals Application Market Size, Share, and CAGR: The segment size is estimated at USD 1.53 billion, contributing 45% to the global market share, and is growing at an average CAGR of 5.7%.

Top 5 Major Dominant Countries in the Hospitals Segment:

• United States: Market size USD 0.50 billion, 33% share, CAGR 5.8%, supported by high surgical volume and advanced infrastructure.
• Germany: Market size USD 0.23 billion, 15% share, CAGR 5.5%, due to strong public healthcare and institutional device procurement.
• Japan: Market size USD 0.18 billion, 12% share, CAGR 5.6%, driven by hospital-based elderly care programs.
• China: Market size USD 0.14 billion, 9% share, CAGR 5.7%, with government hospital expansion and urology care improvements.
• France: Market size USD 0.12 billion, 8% share, CAGR 5.4%, boosted by surgical device reimbursement policies.

Clinics: Clinics serve as essential outpatient centers for urinary incontinence diagnosis and non-surgical treatment. They contribute about 33% of global market demand. Over 45% of clinics worldwide have incorporated wearable urinary management devices. Around 60% of clinic-based cases involve external, non-invasive solutions. This segment benefits from quick patient turnaround, affordability, and increasing public awareness of bladder health. The expansion of private clinics in developing economies has driven a 38% growth in 2024, improving patient accessibility to advanced urinary care.

Clinics Application Market Size, Share, and CAGR: The segment size is approximately USD 1.12 billion, accounting for 33% global share, expanding at a CAGR of 5.5% over the forecast timeline.

Top 5 Major Dominant Countries in the Clinics Segment:

• United States: Market size USD 0.35 billion, 31% share, CAGR 5.6%, driven by strong outpatient care infrastructure.
• United Kingdom: Market size USD 0.15 billion, 13% share, CAGR 5.4%, due to growing non-surgical treatments and early diagnosis programs.
• Japan: Market size USD 0.11 billion, 10% share, CAGR 5.5%, supported by rising geriatric visits in outpatient care.
• Australia: Market size USD 0.09 billion, 8% share, CAGR 5.3%, influenced by improved clinical access and insurance policies.
• India: Market size USD 0.08 billion, 7% share, CAGR 5.6%, driven by private sector investment and patient outreach programs.

Others: The Others category includes home healthcare, rehabilitation centers, and elderly care institutions, collectively contributing around 22% of the total Urinary Incontinence Devices Market. Over 50% of home-based users prefer disposable, sensor-enabled external devices for ease of use and hygiene. Around 40% of rehabilitation centers globally employ portable management systems. The segment’s growth is supported by the rising aging population, telehealth expansion, and demand for at-home care models, with a 35% rise recorded in adoption within the last two years.

Others Application Market Size, Share, and CAGR: The segment size is valued at USD 0.77 billion, holding 22% market share globally, growing at a CAGR of 5.4% over the forecast timeframe.

Top 5 Major Dominant Countries in the Others Segment:

• United States: Market size USD 0.26 billion, 34% share, CAGR 5.5%, led by expanding homecare systems and telehealth platforms.
• Germany: Market size USD 0.09 billion, 12% share, CAGR 5.3%, supported by rehabilitation infrastructure and elderly care centers.
• Japan: Market size USD 0.08 billion, 10% share, CAGR 5.4%, driven by home-use urinary management products for aging populations.
• France: Market size USD 0.07 billion, 9% share, CAGR 5.3%, supported by healthcare digitization and in-home monitoring programs.
• Canada: Market size USD 0.05 billion, 7% share, CAGR 5.4%, boosted by insurance support for at-home urinary management devices.

Urinary Incontinence Devices Market Regional Outlook

The Urinary Incontinence Devices Market demonstrates diverse regional performance across major continents. North America leads with approximately 38% of the global market share, followed by Europe with around 33%, Asia-Pacific at 25%, and the Middle East & Africa holding 9%. North America benefits from advanced healthcare infrastructure, early disease diagnosis, and the presence of leading medical device manufacturers. Europe’s strength lies in high public health awareness, strong reimbursement systems, and regulatory support.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

North America holds the largest portion of the global Urinary Incontinence Devices Market, accounting for approximately 38% share. The regional growth is primarily driven by a large geriatric population, high awareness of bladder disorders, and rapid adoption of advanced medical technologies. Over 25 million individuals in the U.S. and 4 million in Canada are affected by urinary incontinence. More than 6,000 specialized urology centers and 1,200 rehabilitation facilities operate across the region. 

North America Market Size, Share, and CAGR: The North American Urinary Incontinence Devices Market size is approximately USD 2.25 billion, holding 38% global share with a regional CAGR of 5.8%, supported by growing awareness and technological innovation in urological care.

North America - Major Dominant Countries 

• United States: Market size USD 1.83 billion, 31% share, CAGR 5.9%, led by advanced medical infrastructure and high device usage in hospitals and clinics.
• Canada: Market size USD 240 million, 4% share, CAGR 5.6%, driven by aging population and expanding healthcare access in urban centers.
• Mexico: Market size USD 150 million, 2% share, CAGR 5.5%, supported by healthcare reforms and improved access to affordable treatment options.
• Costa Rica: Market size USD 35 million, 0.6% share, CAGR 5.3%, benefiting from medical tourism and rising elderly population.
• Panama: Market size USD 28 million, 0.4% share, CAGR 5.2%, aided by growth in hospital infrastructure and government-led healthcare funding.

EUROPE

Europe holds the second-largest position in the Urinary Incontinence Devices Market with around 33% share. The region is supported by high awareness, favorable medical insurance policies, and increasing adoption of innovative devices. More than 30 million Europeans experience urinary incontinence, and 65% of them are women. Countries such as Germany, France, and the United Kingdom lead the market, accounting for 60% of total European demand. The region has witnessed a 35% growth in external incontinence device adoption and a 28% increase in implantable device usage over the last five years. Europe’s strong healthcare framework, strict product safety regulations, and established reimbursement systems are ensuring consistent adoption across hospital and homecare settings. Advancements in AI-based wearable systems and minimally invasive implants have further improved treatment success rates, increasing patient compliance across the region’s population of over 700 million.

Europe Market Size, Share, and CAGR: The European Urinary Incontinence Devices Market size is approximately USD 1.95 billion, with 33% of global market share and a regional CAGR of 5.6%, driven by healthcare accessibility, reimbursement, and innovation.

Europe - Major Dominant Countries 

• Germany: Market size USD 590 million, 10% share, CAGR 5.6%, supported by advanced hospital systems and reimbursement schemes.
• United Kingdom: Market size USD 470 million, 8% share, CAGR 5.5%, driven by NHS integration of modern urinary management technologies.
• France: Market size USD 350 million, 6% share, CAGR 5.4%, aided by public health awareness and national coverage programs.
• Italy: Market size USD 290 million, 5% share, CAGR 5.3%, due to increasing demand for home-use incontinence devices.
• Spain: Market size USD 230 million, 4% share, CAGR 5.2%, with rising adoption of wearable incontinence monitoring devices.

ASIA-PACIFIC

Asia-Pacific is the fastest-growing region, contributing about 25% of the global Urinary Incontinence Devices Market. The growth is primarily driven by population aging, rising healthcare awareness, and increasing affordability of medical devices. Over 100 million individuals in Asia-Pacific suffer from urinary incontinence, with 60% being women. Japan, China, and India collectively represent 70% of the total regional demand. The introduction of smart, wearable incontinence solutions has increased device penetration by 45% in the last two years. Hospitals and clinics across Asia have reported a 40% rise in incontinence treatments since 2023. Governments across India and China are implementing national programs to promote female hygiene and bladder health, creating a supportive environment for manufacturers. In Japan and South Korea, the integration of AI-based monitoring systems and improved home healthcare options have enhanced treatment quality and accessibility, supporting the region’s strong market trajectory.

Asia-Pacific Market Size, Share, and CAGR: The Asia-Pacific Urinary Incontinence Devices Market size is approximately USD 1.50 billion, representing 25% of the global share, growing at a regional CAGR of 5.9% due to rapid healthcare advancements and demographic shifts.

Asia - Major Dominant Countries 

• Japan: Market size USD 540 million, 9% share, CAGR 5.8%, led by advanced hospital infrastructure and high adoption of wearable incontinence systems.
• China: Market size USD 420 million, 7% share, CAGR 6.0%, supported by expanding public healthcare initiatives and industrial manufacturing capabilities.
• India: Market size USD 240 million, 4% share, CAGR 5.9%, fueled by healthcare reforms and growing female hygiene awareness.
• South Korea: Market size USD 180 million, 3% share, CAGR 5.7%, driven by healthcare digitization and smart home medical devices.
• Australia: Market size USD 120 million, 2% share, CAGR 5.6%, boosted by government-supported elderly care and home treatment programs.

MIDDLE EAST & AFRICA

The Middle East & Africa (MEA) region holds approximately 9% of the Urinary Incontinence Devices Market, showing gradual improvement through healthcare modernization and awareness initiatives. Around 12 million individuals across the region experience urinary incontinence, with women accounting for 70% of cases. Hospitals account for 60% of incontinence device usage, led by Saudi Arabia and the UAE. The adoption of disposable external incontinence devices has grown by 35% since 2022 due to affordability and minimal maintenance. Africa’s major economies, including South Africa and Egypt, are expanding their healthcare capacity, introducing advanced urological centers and training programs for healthcare workers. Government investments and private collaborations are expected to further enhance accessibility. The MEA region’s market is strengthening, supported by technology adoption, medical education, and increased access to diagnostics and early treatment.

Middle East & Africa Market Size, Share, and CAGR: The Middle East & Africa Urinary Incontinence Devices Market size is approximately USD 540 million, holding 9% of the global share with a regional CAGR of 5.5%, driven by healthcare infrastructure expansion and awareness.

Middle East and Africa - Major Dominant Countries 

• Saudi Arabia: Market size USD 180 million, 3% share, CAGR 5.6%, supported by national healthcare investment and hospital modernization.
• United Arab Emirates: Market size USD 120 million, 2% share, CAGR 5.4%, driven by technological innovation and hospital-based adoption.
• South Africa: Market size USD 90 million, 1.5% share, CAGR 5.5%, fueled by improved medical facilities and public health awareness.
• Egypt: Market size USD 60 million, 1% share, CAGR 5.3%, aided by increased healthcare funding and device imports.
• Kuwait: Market size USD 45 million, 0.8% share, CAGR 5.2%, led by rapid healthcare growth and device procurement programs.

List of Top Urinary Incontinence Devices Market Companies

• Boston Scientific Corporation
• Johnson & Johnson
• C. R. Bard
• Coloplast Group

Top Two companies with highest share

• Boston Scientific Corporation: Boston Scientific holds approximately 18% of the global Urinary Incontinence Devices Market share. The company’s strong position stems from its wide product portfolio, including male slings, artificial urinary sphincters, and minimally invasive urological systems. 

• Coloplast Group: Coloplast Group accounts for about 15% of the total global market share and dominates across European and Asia-Pacific regions. The company offers a range of external urinary management devices, including advanced external catheters, discreet wearable pads, and male clamps. 

Investment Analysis and Opportunities

The Urinary Incontinence Devices Market presents major investment opportunities driven by increasing global healthcare expenditure and rapid technological progress. More than 45% of leading medical device companies have expanded their investments in non-invasive and digital urinary management systems. Between 2023 and 2025, over 120 funding deals were completed globally in this sector, indicating a 30% increase from previous periods. Investment priorities include wearable smart pads, AI-powered leakage detection systems, and remote monitoring platforms. Around 40% of global venture funding for urinary incontinence devices is concentrated in North America and Asia-Pacific, supported by government innovation grants and private equity involvement. Healthcare reforms in over 25 countries have enhanced insurance coverage for incontinence treatment, opening pathways for sustainable investments. Additionally, multinational corporations are investing in eco-friendly materials and recyclable devices to meet global sustainability targets, further expanding opportunities for investors and stakeholders in the medical technology industry.

New Product Development

Continuous innovation defines the Urinary Incontinence Devices Market, with more than 60 new device launches recorded globally between 2023 and 2025. Manufacturers are focusing on enhancing device comfort, durability, and clinical effectiveness through smart technologies and biocompatible materials. Boston Scientific introduced an upgraded artificial urinary sphincter in 2024, reducing surgical revision rates by 22%. Coloplast launched a smart wearable urinary management system with integrated moisture sensors, achieving a 90% user compliance rate. Johnson & Johnson developed a lightweight, patient-specific pelvic sling that improved recovery times by 35%. Meanwhile, C. R. Bard released a novel, antimicrobial-coated catheter that lowered infection rates by 28% in clinical trials. Across major hospitals, the adoption of robotic-assisted implantation techniques has increased by 30%, improving patient outcomes and surgical precision. This surge in innovation underscores the market’s transformation toward connected, patient-friendly, and data-driven urinary incontinence management solutions.

Five Recent Developments

• In 2023, Johnson & Johnson launched an advanced non-surgical incontinence support system, improving treatment outcomes by 27% and reducing patient recovery time by nearly 20%.
• In 2024, Boston Scientific expanded its urology division by acquiring two startups focused on AI-integrated leakage detection, strengthening its presence in 25 international markets.
• Coloplast introduced a micro-sensor-enabled external catheter in 2024 that reduced urinary leakage incidents by 33% among chronic patients.
• In 2025, C. R. Bard collaborated with a leading healthcare analytics firm to develop digital catheters capable of collecting real-time diagnostic data for hospitals.
• Medtronic initiated human trials in 2025 for a wireless neurostimulation system that reduced urge incontinence episodes by 40% during preliminary testing phases.

Report Coverage of Urinary Incontinence Devices Market

The Urinary Incontinence Devices Market Report provides an in-depth overview of market dynamics, segmentation, competitive analysis, and future projections across major global regions, including North America, Europe, Asia-Pacific, and the Middle East & Africa. It covers both internal and external urinary incontinence device categories, such as catheters, slings, clamps, artificial sphincters, and wearable pads. The report analyzes data from more than 50 countries and includes insights from over 100 manufacturers. It evaluates market structure, regional performance, key technological advancements, and end-user adoption trends in hospitals, clinics, and homecare settings. Additionally, it highlights investment opportunities, product pipeline assessments, and regulatory frameworks shaping market progress. The report further explores product lifecycle trends, clinical efficiency improvements, and R&D pipelines driving market innovation. By focusing on performance metrics and adoption drivers, the report offers comprehensive insights for investors, manufacturers, and healthcare providers aiming to strengthen their strategic positioning in the global urinary incontinence devices industry.

Urinary Incontinence Devices Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 14713.9 Million in 2026
Market Size Value By	USD 24843.74 Million by 2035
Growth Rate	CAGR of 5.3% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : External Urinary Incontinence Devices Internal Urinary Incontinence Devices By Application : Hospitals Clinics Others
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample